Japanese study of the outcome of hormonally controlled FET cycles using OneCrinone as luteal support - J-FOCAL study

Clinical Research Support Center Kyushu0 sites180 target enrollmentFebruary 2, 2018

Overview

No summary available.

Registry

who.int

Start Date

February 2, 2018

End Date

June 30, 2020

Last Updated

2 years ago

Study Type

Interventional

Sex

Female

Sponsor

Clinical Research Support Center Kyushu

•1\)Natural ovulation may be expected (mature follicles observed). 2\)History of recurrent pregnancy loss (defined as 3 or more previous spontaneous abortions) 3\)History of 3 or more consecutive cancelled or failed (no clinical pregnancy) ET cycles. 4\)Underwent ovarian stimulation using clomiphene citrate in the previous cycle and not having menstruation following oocyte retrieval. 5\)Abnormal hemorrhage of the reproductive tract of undetermined origin 6\)Any contraindication to being pregnant and/or carrying a pregnancy to term 7\)Endometriosis, uterine myoma, adenomyosis uteri, or uterine polyps requiring treatment 8\)Extra\-uterine pregnancy within the last 3 months prior to the date of informed consent 9\)Ovarian enlargement or cyst of unknown etiology 10\)Breast\-feeding or lactation 11\)Known Human Immunodeficiency Virus (HIV)\-positive status, or a history of or current active infection with Hepatitis B or C. 12\)History of allergy or hypersensitivity to progesterone preparations and/or their excipients, or any contraindication to receive progesterone preparations 13\)History of or suspected alcohol or substance abuse within 5 years prior to the date of informed consent 14\)Active thrombophlebitis, thromboembolic disorder or cerebral stroke, or a history of such conditions. 15\)Judged as ineligible in the opinion of the site investigator or investigator.